(Q47574212)

4 February 2018

title

Lithium treatment in amyotrophic lateral sclerosis: do we have enough trials? (English)

1 reference

4 February 2018

amyotrophic lateral sclerosis

main subject

0 references

author

Mamede de Carvalho

series ordinal

1

1 reference

4 February 2018

Susana Pinto

series ordinal

2

1 reference

4 February 2018

publication date

1 December 2011

1 reference

4 February 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

4 February 2018

volume

11

1 reference

4 February 2018

issue

12

1 reference

4 February 2018

page(s)

1693-1698

1 reference

4 February 2018

Incidence of amyotrophic lateral sclerosis in Europe

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Amyotrophic lateral sclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

The role of patients and patient advocacy groups in educating patients on the importance of legitimate scientific research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

21 January 2018

Autophagy and metabolism

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Loss of autophagy in the central nervous system causes neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Lithium in the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Lithium delays progression of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

21 January 2018

Lithium therapy in ALS

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.164

21 January 2018

Identifiers

DOI

10.1586/ERN.11.164

1 reference

4 February 2018

1 reference

4 February 2018